XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 40.83

Change

-0.24 (-0.58)%

Market Cap

CAD 0.48B

Volume

2.76K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.33 (-0.24%)

CAD 17.00B
ZSP:CA BMO S&P 500

-0.24 (-0.28%)

CAD 16.26B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.18 (+0.30%)

CAD 10.74B
VUN:CA Vanguard US Total Market

-0.34 (-0.33%)

CAD 9.46B
XUS:CA iShares Core S&P 500 Index ETF

-0.15 (-0.31%)

CAD 7.29B
HXS:CA Global X S&P 500 Corporate Cla..

-0.28 (-0.35%)

CAD 4.01B
VSP:CA Vanguard S&P 500 CAD hedged

+0.19 (+0.20%)

CAD 3.45B
QUU:CA Mackenzie US Large Cap Equity ..

+0.19 (+0.09%)

CAD 3.22B
XUU:CA iShares Core S&P US Total Mark..

-0.36 (-0.63%)

CAD 3.05B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.23 (+0.46%)

CAD 2.96B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.17% 85% B 81% B-
Dividend Return 0.80% 51% F 25% F
Total Return 22.97% 90% A- 81% B-
Trailing 12 Months  
Capital Gain 33.26% 78% C+ 81% B-
Dividend Return 1.23% 33% F 27% F
Total Return 34.49% 78% C+ 81% B-
Trailing 5 Years  
Capital Gain 94.89% 82% B 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 94.89% 72% C 83% B
Average Annual (5 Year Horizon)  
Capital Gain 13.72% 78% C+ 80% B-
Dividend Return 14.51% 78% C+ 78% C+
Total Return 0.79% 20% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 14.42% 44% F 56% F
Risk Adjusted Return 100.65% 71% C- 97% N/A
Market Capitalization 0.48B 53% F 58% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.